Advertisement

Osteoporosis International

, Volume 26, Issue 12, pp 2869–2875 | Cite as

Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service

  • A. Amouzougan
  • A. Deygat
  • B. Trombert
  • E. Constant
  • D. Denarié
  • H. Marotte
  • T. ThomasEmail author
Original Article

Abstract

Summary

In a population of postmenopausal women with a fragility fracture, we found a drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D, especially from 2009 onwards. These results show that supplementation has been very widely integrated into current practice.

Introduction

Vitamin D (25(OH)D) is essential for bone health. In institutionalised osteoporotic women, it reduces the risk of fragility fractures. Numerous articles suggesting the possibility of extraosseous effects have generated a growing number of publications and recommendations on more widespread administration, to limit the risks of moderate or severe hypovitaminosis D. We assessed the impact on clinical practice of these recommendations concerning 25(OH)D supplementation in elderly at-risk populations.

Methods

A total of 1486 postmenopausal osteoporotic women were seen in the context of a fracture liaison service (i.e. a rheumatology consultation following a peripheral fragility fracture), between May 2005 and December 2012. Of these, 1107 had a 25(OH)D assay (femur, n = 520; humerus, n = 207; wrist, n = 380).

Results

The average age of the total population was 76.7 ± 9.9 years, while for women with an available 25(OH)D assay, the average age was 75.1 ± 11.8 years. The average 25(OH)D (nmol/L) level was similar for the three fracture sites: femur, 30 ± 36.2; humerus, 27.5 ± 24; and wrist, 31 ± 26. A drastic reduction in the proportion of women with severe (<25 nmol/L) and moderate (25 to 75 nmol/L) hypovitaminosis D was observed, especially from 2009 onwards, with a mean prevalence of 69 and 30 % respectively before that year and 35 and 52 % thereafter. Conversely, the proportion of women with 25(OH)D at the threshold value of 75 nmol/L increased from 1.2 to 24 %. Overall, mean serum 25(OH)D levels were significantly higher when comparing the two periods 2005–2008 and 2009–1012 (17.6 ± 14.6 and 48.4 ± 39.2 nmol/L, respectively; p < 0.0001).

Conclusion

These results show that supplementation has been very widely integrated into current practice. We can expect it to yield beneficial effects in osseous and extraosseous terms in osteoporotic women, particularly the very elderly.

Keywords

Fracture liaison service Fragility fractures Postmenopausal osteoporosis Recommendations Vitamin D 

Notes

Conflicts of interest

None.

References

  1. 1.
    Noh CK, Lee MJ, Kim BK et al (2013) A case of nutritional osteomalacia in young adult male. J Bone Metab 20:51–55PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Souberbielle JC, Prié D, Courbebaisse M et al (2008) Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris) 69:501–510CrossRefGoogle Scholar
  3. 3.
    Bhan A, Rao AD, Rao DS (2012) Osteomalacia as a result of vitamin D deficiency. Rheum Dis Clin North Am 38:81–91CrossRefPubMedGoogle Scholar
  4. 4.
    Mac-Way F, Azzouz L, Noel C et al (2014) Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction. J Bone Miner Metab 32:215–219CrossRefPubMedGoogle Scholar
  5. 5.
    Grados F, Brazier M, Kamel S et al (2003) Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine 70:203–208CrossRefPubMedGoogle Scholar
  6. 6.
    Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40–49CrossRefPubMedGoogle Scholar
  7. 7.
    Avenell A, Mak JC, O'Connell D (2014) Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4, CD000227PubMedGoogle Scholar
  8. 8.
    Lips P, Gielen E, van Schoor NM (2014) Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep 3:512PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Szulc P, Meunier PJ (2003) Synergistic effect of vitamin D and calcium in preventing proximal femoral fractures in older patients. Joint Bone Spine 70:157–160CrossRefPubMedGoogle Scholar
  10. 10.
    Peris P, Martínez-Ferrer A, Monegal A et al (2012) 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone 51:54–58CrossRefPubMedGoogle Scholar
  11. 11.
    Ralston SH, Binkley N, Boonen S et al (2011) FOCUS-D (FOSAVANCE vs. Standard Care-Use and Study of Vitamin D) Trial. Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency. Calcif Tissue Int 88:485–494CrossRefPubMedGoogle Scholar
  12. 12.
    Vink-van Wijngaarden T, Pols HA, Buurman CJ et al (1994) Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. Cancer Res 54:5711–5717PubMedGoogle Scholar
  13. 13.
    Marra A, Leoncini G, Mussap M et al (2014) Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients. Int J Clin Pract 68:647–652CrossRefPubMedGoogle Scholar
  14. 14.
    Liu ZM, Woo J, Wu SH et al (2013) The role of vitamin D in blood pressure, endothelial and renal function in postmenopausal women. Nutrients 5:2590–2610PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Sundaram ME, Coleman LA (2012) Vitamin D and influenza. Adv Nutr 3:517–525PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Peterlik M, Cross HS (2006) Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26:2581–2588PubMedGoogle Scholar
  17. 17.
    Miyakoshi N, Sasaki H, Kasukawa Y et al (2010) Effects of a vitamin D analog, alfacalcidol, on bone and skeletal muscle in glucocorticoid-treated rats. Biomed Res 31:329–336CrossRefPubMedGoogle Scholar
  18. 18.
    Gezmish O, Tare M, Parkington HC et al (2010) Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci 17:168–176CrossRefPubMedGoogle Scholar
  19. 19.
    Suetani RJ, Ho K, Jindal S et al (2012) A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues. Mol Cell Endocrinol 362:202–210CrossRefPubMedGoogle Scholar
  20. 20.
    Benhamou CL, Souberbielle JC, Cortet B et al (2011) La vitamine D chez l’adulte: recommandation du GRIO. Presse Med 40:673–682CrossRefGoogle Scholar
  21. 21.
    Souberbielle JC, Benhamou CL, Cortet B et al (2014) HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation. Presse Med 43:5–8CrossRefPubMedGoogle Scholar
  22. 22.
    Reid IR, Bolland MJ (2014) Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int 25:2347–2357CrossRefPubMedGoogle Scholar
  23. 23.
    Theodoratou E, Tzoulaki I, Zgaga L et al (2014) Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 348:g2035PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Bolland MJ, Grey A, Gamble GD et al (2014) Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2:573–580CrossRefPubMedGoogle Scholar
  25. 25.
    Reid IR, Bolland MJ, Grey A (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383:146–155CrossRefPubMedGoogle Scholar
  26. 26.
    Dawson-Hughes B, Heaney RP, Holick MF et al (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716CrossRefPubMedGoogle Scholar
  27. 27.
    Lamberg-Allardt C, Brustad M, Meyer HE et al (2013) Vitamin D - a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations. Food Nutr Res 57:22671CrossRefGoogle Scholar
  28. 28.
    Zarca K, Durand-Zaleski I, Roux C et al (2014) Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: a Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture. Osteoporos Int 25:1797–1806CrossRefPubMedGoogle Scholar
  29. 29.
    Amouzougan A, Chopin F, Laporte S et al (2012) Functional hypoparathyroidism in postmenopausal women with fragility fracture. Joint Bone Spine 79:170–175CrossRefPubMedGoogle Scholar
  30. 30.
    Boudou L, Gerbay B, Chopin F et al (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 22:2099–2106CrossRefPubMedGoogle Scholar
  31. 31.
    Maravic M, Le Bihan C, Landais P et al (2005) Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int 16:1475–1480CrossRefPubMedGoogle Scholar
  32. 32.
    Couris CM, Chapurlat RD, Kanis JA et al (2012) FRAX® probabilities and risk of major osteoporotic fracture in France. Osteoporos Int 23:2321–2327CrossRefPubMedGoogle Scholar
  33. 33.
    Romero-Ortuno R, Cogan L, Browne J, Healy M, Casey MC, Cunningham C, Walsh JB, Kenny RA (2011) Seasonal variation of serum vitamin D and the effect of vitamin D supplementation in Irish community-dwelling older people. Age Ageing 40:168–174CrossRefPubMedGoogle Scholar
  34. 34.
    Theiler R, Stahelin HB, Kranzlin M, Somorjai G, Singer-Lindpaintner L, Conzelmann M, Geusens P, Bischoff HA (2000) Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly. Eur J Endocrinol 143:673–679CrossRefPubMedGoogle Scholar
  35. 35.
    Moyer VA, U.S. Preventive Services Task Force (2012) Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:197–204CrossRefPubMedGoogle Scholar
  36. 36.
    Briot K, Audran M, Cortet B et al (2009) Vitamin D: skeletal and extra skeletal effects; recommendations for good practice. Press Med 38:43–54CrossRefGoogle Scholar
  37. 37.
    Nelson SA, Dresser GK, Vandervoort MK et al (2011) Barriers to blood pressure control: a STITCH substudy. J Clin Hypertens (Greenwich) 13:73–80CrossRefGoogle Scholar
  38. 38.
    Dasgupta K, Quinn RR, Zarnke KB et al (2014) The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 30:485–501CrossRefPubMedGoogle Scholar
  39. 39.
    Egli M, Ruiz J (2011) Diabetes. Perspectives on the management of diabetes in 2010. Rev Med Suisse 7:113–116PubMedGoogle Scholar
  40. 40.
    Smolen HJ, Murphy DR, Gahn JC et al (2014) The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus. J Manag Care Pharm 20:968–984Google Scholar
  41. 41.
    Klarenbeek NB, Güler-Yüksel M, van der Kooii SM et al (2011) The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Ann Rheum Dis 70:1039–1046CrossRefPubMedGoogle Scholar
  42. 42.
    Knevel R, Schoels M, Huizinga TW et al (2010) Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:987–994CrossRefPubMedGoogle Scholar
  43. 43.
    Bjelakovic G, Gluud LL, Nikolova D et al (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1, CD007470PubMedGoogle Scholar
  44. 44.
    Basit S (2013) Vitamin D in health and disease: a literature review. Br J Biomed Sci 70:161–172PubMedGoogle Scholar
  45. 45.
    Ryan JW, Anderson PH, Turner AG et al (2013) Vitamin D activities and metabolic bone disease. Clin Chim Acta 425:148–152CrossRefPubMedGoogle Scholar
  46. 46.
    Mosekilde L (2005) Vitamin D and the elderly. Clin Endocrinol (Oxf) 62:265–281CrossRefGoogle Scholar
  47. 47.
    Dawson-Hugues B, Mithal A, Bonjour JP et al (2010) IOF position statements: vitamin D recommandations for older adults. Osteoporosis Int 21:1151–1154CrossRefGoogle Scholar
  48. 48.
    Chapuy MC, Preziosi P, Maamer M et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443CrossRefPubMedGoogle Scholar
  49. 49.
    Lamberg-Allardt CJ, Outila TA, Kärkkainen MU et al (2001) Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16:2066–2073CrossRefPubMedGoogle Scholar
  50. 50.
    Cheng S, Tylavsky F, Kröger H et al (2003) Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepupertal Finnish girls. Am J Clin Nutr 78:485–492PubMedGoogle Scholar
  51. 51.
    HAS (2013). Utilité Clinique du dosage de la vitamine D – Rapport d’évaluation technologique. St-Denis: HAS ;2013 ([http://www.has-sante.fr/portail/jcms/c_1356838/frutilite-clinique-du-dosage-de-la-vitamine-d-rapport-d-evaluation])
  52. 52.
    Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2015

Authors and Affiliations

  • A. Amouzougan
    • 1
    • 2
  • A. Deygat
    • 1
    • 2
  • B. Trombert
    • 3
    • 4
  • E. Constant
    • 1
    • 2
  • D. Denarié
    • 1
    • 2
  • H. Marotte
    • 1
    • 2
  • T. Thomas
    • 1
    • 2
    Email author
  1. 1.INSERM U1059, Lab Biologie Intégrée du Tissu OsseuxUniversité de LyonLyonFrance
  2. 2.Rheumatology DepartmentUniversity Hospital of Saint-EtienneSaint-EtienneFrance
  3. 3.SSPIMUniversity Hospital of Saint-EtienneSaint-EtienneFrance
  4. 4.EA SNA-EPISPRES LyonSaint-EtienneFrance

Personalised recommendations